Insider Buying Activity Uncovered - 5 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Game-Changing Cancer Tech Nears FDA Completion]( [Explore Investment Opportunities in This Market Disruptor]( --------------------------------------------------------------- April 3, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Revolutionary Device Redefines Cancer Detection]( the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time. [Learn More Now - Before Anticipated FDA Approval in 2024]( --------------------------------------------------------------- [Citi Trends, Inc.]( Ticker: [CTRN]( Recent Price: $27.02 Average Analyst Price Target: $28.33 (4.86%) Market Cap: $230.87M Role Transaction Description No. of Shares Amount Date >10% Owner Informative Buy Non Open Market Buy 18,000 $487,760 2 Days Ago Recent Analyst Action: Michael Baker, analyst at D.A. Davidson, reiterates coverage on [Citi Trends, Inc. (CTRN)]( in the Consumer Cyclical sector with a Buy rating (2 weeks ago). Here are 3rd party ratings for [CTRN](: - TipRanks.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Ameresco, Inc.]( Ticker: [AMRC]( Recent Price: $23.86 Average Analyst Price Target: $34.00 (42.50%) Market Cap: $1.25B Role Transaction Description No. of Shares Amount Date Director Informative Buy Options Exercised and fully kept 10,000 $67,000 2 Days Ago Recent Analyst Action: Pavel Molchanov, analyst at Raymond James, reiterates coverage on [Ameresco, Inc. (AMRC)]( in the Industrials sector with a Buy rating and a price target of $35 (9 hours ago). Here are 3rd party ratings for [AMRC](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Strong Sell, Top 24% (60 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Video: This is AI's "Oppenheimer Moment"]( 40-year AI pioneer reveals a mysterious project that could help us unlock a $22.1 trillion "age of abundance" by 2030. It might be our best bet to ensure AI is a powerful force for good, like nuclear power. And not a destructive force like a nuclear bomb. That's why it could also generate an unbelievable wealth explosion for investors. [(Full story…)]( --------------------------------------------------------------- [Greenwich LifeSciences, Inc.]( Ticker: [GLSI]( Recent Price: $17.49 Average Analyst Price Target: $36.00 (105.83%) Market Cap: $224.72M Role Transaction Description No. of Shares Amount Date CEO and CFO,Director, >10% Owner Informative Buy Non Open Market Buy 3,272 $57,240 2 Days Ago Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [Greenwich LifeSciences, Inc. (GLSI)]( in the Healthcare sector with a Buy rating and a price target of $36 (1 month ago). Here are 3rd party ratings for [GLSI](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 29% (74 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Inspire Medical Systems, Inc.]( Ticker: [INSP]( Recent Price: $205.06 Average Analyst Price Target: $239.00 (16.55%) Market Cap: $6.07B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 255 $52,368 2 Days Ago Recent Analyst Action: Travis Steed, analyst at Bank of America Securities, reiterates coverage on [Inspire Medical Systems, Inc. (INSP)]( in the Healthcare sector with a Buy rating and a price target of $265 (1 week ago). Here are 3rd party ratings for [INSP](: - TipRanks.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Bottom 42% (146 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [GPT-4 vs. X.AI: The Race of the New AI Giants]( smart money investors all know AI is the wave of the future and could mean huge profits for anyone involved. AI has been called the biggest new industry of the 21st century. Experts are projecting it will be worth a staggering $80 trillion over the next 10 years. And right now, Chief Investment Strategist Adam O’Dell is revealing his favorite X.AI stock you should check out today. [Click here to see the full story now.]( --------------------------------------------------------------- [CalciMedica, Inc.]( Ticker: [CALC]( Recent Price: $4.04 Average Analyst Price Target: $18.25 (351.73%) Market Cap: $41.44M Role Transaction Description No. of Shares Amount Date CBO,Director, >10% Owner Informative Buy Non Open Market Buy 4,000 $15,600 2 Days Ago Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [CalciMedica, Inc. (CALC)]( in the Healthcare sector with a Buy rating and a price target of $20 (2 days ago). Here are 3rd party ratings for [CALC](: - TipRanks.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Top 29% (74 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Presidential candidate your should REALLY be worried about]( Americans are overlooking the seemingly impossible candidate that should worry you. It's not Biden… Trump… Newsom… or even Michelle. It's someone even worse. New evidence of a secret plan indicates he could soon return, and finish what he started. [Get the full story right here.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor MarketSectorDaily.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be third-party advertisements where the advertiser is paying per click, per lead, or per sale and are not endorsed or warranted by our staff or company. SPMG, MarketSectorDaily.com and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged not to use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. SPMG, MarketSectorDaily.com nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from SPMG or MarketSectorDaily.com to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketSectorDaily.com MarketSectorDaily.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Mt. Mourne | North Carolina | 28123 | United States | 8774119808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software